Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Gynecologic 1

Conditions

Motor Activity 9Neoplasms 4Colorectal Neoplasms 4Prostatic Neoplasms 3Pancreatic Neoplasms 3Obesity 3Breast Neoplasms 3Brain Neoplasms 3Sarcopenia 2Multiple Myeloma 2Weight Loss 1Triple Negative Breast Neoplasms 1Thrombocythemia, Essential 1Smoldering Multiple Myeloma 1Skin Neoplasms 1Renal Insufficiency, Chronic 1Rehabilitation Exercise 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Overweight 1Neoplasms, Plasma Cell 1Myeloproliferative Disorders 1Melanoma 1Lymphoma, B-Cell 1Lymphoma 1Lymphedema 1Lung Neoplasms 1Locally Advanced Head and Neck Squamous Cell Carcinoma 1Leukemia, Myeloid, Acute 1

Interventions

Megestrol Acetate 4Progestins 3Tirzepatide 2Letrozole 2Biopsy 2semaglutide 1exemestane 1Tamoxifen 1Surveys and Questionnaires 1Sampling Studies 1Restraint, Physical 1Resistance Training 1Pterocarpus marsupium 1Pharmacogenomic Variants 1Observation 1Nutrition Assessment 1Metformin 1Medroxyprogesterone Acetate 1Magnetic Resonance Spectroscopy 1LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1Intrauterine Devices 1Hysteroscopy 1Hysterectomy 1Everolimus 1Estrogen Replacement Therapy 1Cyproterone acetate, ethinyl estradiol drug combination 1Curettage 1Blood Specimen Collection 13,5-dimethoxy-4'-hydroxystilbene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Endometrial Hyperplasia × Resistance Training × 1 year × Clear all
NCT07462663 2026-05-13

SHAPE-ENDO

Hospital Universitari de Bellvitge

Phase 4 Not yet recruiting
82 enrolled
GynecologicOther

Endometrial Hyperplasia, Neoplasms, Obesity, Endometrial Neoplasms, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡